SHMN is taking on India and Asia

Some online brokers require you to call in orders for thinly traded companies. Keep this in mind if you ever wish to get involved with SHMN.

Make sure you keep a close eye on SHMN because when it ran in the Summer, the results were gains of over 150%. I don't know if this will ever happen again but it can clearly move!!

Generic medicines cost about 30% to 80% less than the brand name ones!

SHMN could see some rapid growth as more and more consumers and physicians are accepting generic medicines today.

Major stores like Walmart are offering generics for only $4.

SHMN is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories.

Generic pharmaceuticals are the chemical and therapeutic equivalents of brand-name drugs and are typically sold under their chemical names at prices substantially below those of the brand-name pharmaceuticals.

Generics are required to meet similar governmental regulations as their brand-name equivalents and must receive regulatory approval prior to their sale in any given country.

The fact that SHMN has manufacturing sites in India makes the company very promising in my opinion.

SHMN's manufacturing facility is located in Ahmedabad City, India, in an area considered one of the safest in India and perfect for pharmaceutical operations.

India has a significant share in the global generics market and is ranked third in the world!

The domestic pharmaceutical market in India is significant at around $10 billion in annual sales and annual growth rates have doubled for the domestic market from 7% to 14% over the past couple years.

SHMN has expanded its distribution network for generic pharmaceuticals in four Northern states of India.

India is one of the only emerging markets that has many of the leading pharmaceutical multinationals listed and publicly traded on domestic stock exchanges, including Pfizer, Novartis, and GlaxoSmithKline!

A large percentage of the world's population needs basic pharmaceuticals but can't afford branded drugs because they are either too expensive or not available due to high prices.

So SHMN is shifting focus away from developed markets in the U.S. and Europe and towards emerging markets as less developed countries prosper and spend more money on health care.

These un-served or underserved niche markets could be very profitable for SHMN.

Emerging markets like Africa, Latin America, and Southeast Asia could be very lucrative for SHMN.

SHMN is expanding its generic drug distribution within the emerging pharmaceutical market in Southeast Asia; specifically in Indonesia, Thailand, the Philippines, and Malaysia.

SHMN is positioned to capitalize on the health issues not being addressed such as different contagious diseases and life style disorders such as cardiovascular, diabetes, musculoskeletal disorders and cancer to expand the market and serve the populations of these countries.

Southeast Asia is the fourth-largest pharmaceutical market in the world, behind the United States, Japan, and Europe.

Southeast Asia is also the world's fastest-growing pharmaceutical market.

Factors driving this market expansion include economic growth, a broadening middle class, growing and aging population,20increasing economic liberalization, and an expanded government and private-sector role in improving health care.

Vice President for Corporate Strategy at SHMN Shailesh Shah commented, "Despite the challenges in the current economic climate much of the populations of these countries have a great need for basic pharmaceuticals that are either too expensive or not available to vast populations in this region."

Senior citizens have been repeatedly urged to use generic drugs because they provide for large savings.

SHMN believes that together with an aging population and a corresponding increase in health care costs, as well as the large number of branded products losing patent protection over the coming years, should lead to continued global expansion of the generic pharmaceuticals market!

More information on SHMN is available at their website: www.sohm.com Always do your own research and consult with your own financial professional.